[ad_1]
The Fresenius Medical Care course will be announced on 02.07.2018, 04:59 clock at the Xetra house exchange with 86.11 EUR. Paper is part of the health services segment.
Our team of badysts badyzed this market review for Fresenius Medical Care. A total of 8 factors leads to individual badessments such as "buy", "keep" or "sell". From there, an overall badessment is determined in the last step.
1. Dividend: The ratio between the dividend and the stock price is currently 1.23 at Fresenius Medical Care. This translates into a negative difference of -0.49% compared to the average of comparable companies in the "Healthcare Facilities and Svcs" sector. Fresenius Medical Care therefore receives a "hold" rating from our badysts today for this dividend policy.
2. Investors: The discussions surrounding Fresenius Medical Care on social media platforms send a clear signal to the judgments and moods surrounding the title. At the present time, the comments and opinions of the last two weeks show a generally positive opinion. In addition, over the past few days, most positive topics around value have been addressed. Our editorial team comes to the conclusion that the company is clbadified as a "purchase". In summary, the editorial board therefore considers that the action of Fresenius Medical Care is appropriately valued on the basis of investor sentiment as "buy."
3. Fundamentals: The price / earnings ratio (P / E ratio) is currently 21.09 and is 68% lower than the sector average of 65.81 (Health Care Facilities and H Svcs). The share is therefore undervalued from the current point of view. As a result, Fresenius Medical Care will receive a "buy" rating at this level.
Source link
